Hepatic epithelioid hemangioendothelioma (HEHE) is a rare vascular tumor first named by Weiss[@b1-asm-4-334] in 1982, and is common in middle-aged women with unknown cause. HEHE usually attacks soft tissue, lung, bone, brain, and small intestine, etc., but seldom onsets in liver. HEHE originates from mesenchymal tissue, whose degree of malignance is between hepatic hemangioma and angiosarcoma. Most patients were asymptomatic. Though there are certain imaging characteristics, the diagnosis is still difficult. In this study, we collected and analyzed clinical data and imaging findings of 15 HEHE cases from 1999--2010 in our hospital, and managed to draw some conclusions on its characteristics.

METHODS
=======

In the cohort of 15 patients, 13 cases were confirmed HEHE by tumor paraffin biopsies after hepatectomies, and the other 2 cases were confirmed by liver biopsy under the guidance of ultrasound B-scans. All patients underwent routine ultrasound B-scans, computed tomography (CT), and/or magnetic resonance imaging (MRI) tests, and the clinical and imaging data of all patients were collected and reviewed. All patients were imaged by 64-slice spiral CT and/or 1.5T MRI scanner, examining liver, gallbladder, pancreas, and spleen. Plain scanning was done first, followed by hepatic arterial (HA) phase and portal vein (PV) phase, and then delayed phase with layer thickness at 1 mm and layer spacing at 5 mm. All patients were followed up by telephone.

RESULTS
=======

Clinical features
-----------------

A total of 10 female patients and 5 male patients were included in this cohort, with the female-to-male ratio as 2:1. The mean and median ages were 56 and 40 years, respectively (range, 20--80 years). Seven (46.7%) patients had abdominal discomfort, including epigastric region pain or right hypochondriac region disorder. The other 8 (53.3%) patients were admitted in our hospital after discovering intrahepatic occupying lesions without obvious symptoms. Laboratory examination results did not show common specific features: 8 cases had low ALB/GLB (A/G ratio) (reference value is 1.5--2.5 in our hospital); 3 cases had mild anemia (reference value is 120--160 g/L in our hospital); 1 case had high alanine aminotransferase (ALT) level (reference value is 40 U/L in our hospital); and 1 case was HBsAg positive. α-fetoprotein (AFP), carcinoembryonic antigen (CEA), and CA19-9 levels in all patients were normal, and none of all patients had hepatitis C virus (HCV) infection.

CT and MRI findings
-------------------

Tumor number: Multiple intrahepatic nodular were found in 9 out of 15 (60%) HEHE cases; and single nodular were found in the other 6 cases (40%). Tumor appearance: Twelve ovals and 3 irregular shaped. All lesions were in low density under plain CT scanning without local calcification. Dynamic enhanced CT scanning demonstrated peripheral enhancement in the HA phase and even more peripheral enhancement in the PV phase, and ring enhancement were detected under delayed scanning ([Figure 1](#f1-asm-4-334){ref-type="fig"}). MRI demonstrated low-density lesions and even lower density lesion centers in T1-weighted images (T1WI), but slightly high signal intensity lesions and higher intensity lesion centers in T2WI. Enhanced MRI scanning showed ring enhancements but no obvious enhanced centers. Lesions were further enhanced in delayed MRI scanning ([Figure 2](#f2-asm-4-334){ref-type="fig"}) There is a characteristic image call "capsular retraction" due to the fact that the fiber matrix components of a tumor produce fiber contractile response in the surrounding liver parenchyma. In this cohort, 5 cases were initially diagnosed with metastatic liver cancer, 3 cases with cholangiocellular carcinoma, 1 case with hepatic cavernous hemangioma, 1 case with intrahepatic diffused hepatocellular carcinoma, 1 case with hepatic cystadenoma, 1 case with primary liver cancer and 1 case with intrahepatic uneven fatty infiltration.

Treatment and follow-up
-----------------------

Thirteen patients underwent surgical procedures, including 4 orthotopic liver transplantation (OLT) cases, and 3 of them received transcatheter arterial chemoembolization (TACE) treatment after surgeries. The other 2 patients underwent TACE treatment after final diagnosed as HEHE. Twelve out of 15 patients survived at the last follow-up ([Table 1](#t1-asm-4-334){ref-type="table"}).

DISCUSSION
==========

HEHE is a kind of rare hepatic primary tumor, with an incidence lower than 1/1 000 000.[@b2-asm-4-334] Its degree of malignance is between hepatic hemangioma and angiosarcoma. Although the etiology of HEHE is unknown, it may associate with oral contraceptives, liver trauma history, long-term inhalation, and exposure to vinyl chloride. HEHE usually occurs in adults, especially in women, with a young onset age between 30 and 40 years old.[@b3-asm-4-334]--[@b5-asm-4-334] Min-Shu et al[@b6-asm-4-334] reported that the female-to-male ratio was 5:1, and the onset age was from 25 to 86 years old---mostly between 30 and 40 years old. In the 15 cases we collected in our hospital, there were 10 female and 5 male patients, with the female-to-male ratio as 2:1, and the onset age was from 20 to 80 years old, while 8 of them (53.3%) were between 33 and 48 years old, which is similar to the data in Min-Shu Hsieh's report. Most HEHE patients are asymptomatic. In this study, 8 patients (53.3%) were discovered in regular health examinations without obvious discomfort, and the other 7 patients had epigastric region pain or their right-side hepatic region was unwell. No typical specificity was observed in laboratory examinations: routine tumor markers such as AFP, CEA, CA19-9, etc., were all in the normal range; only the ALT level was abnormally increased.[@b7-asm-4-334] Min-Shu Hsieh et al[@b6-asm-4-334] reported that 1 out of 6 HEHE patients had elevated ALT and aspartate aminotransferase levels, and 2 HEHE had mild anemia. In our study, there were 8 low A/G ratio cases, 3 mild anemia cases, 1 high ALT level case, and 1 HBsAg positive case. AFP, CEA, and CA19-9 levels in all patients were normal, and none of the patients had HCV infection.

HEHE patients usually have multiple nodular. Min-Shu Hsieh[@b6-asm-4-334] reported 6 cases, in which 4 cases had multiple nodular and 2 cases had single nodular. In this cohort, 9 out of 15 (60%) patients had multiple nodular, presenting intrahepatic low echo under ultrasound B-scans, with a low blood low signal and sometimes a slightly flow signal at the edge, showing characteristics similar to hepatic metastases without specificity. However, there were certain features in CT and MRI examinations. Jiang and Yuan reported 79 intrahepatic nodular in 9 patients and found low-density in all nodular, and even lower signal inside nodular; except 1 single-nodular patient, among the other 78 nodular in 8 patients, there were 26 nodular made by nodule combinations, and only 2 calcified nodular; 7 patients had capsular retractions; most patients had slight enhancement around lesions in the enhanced HA phase imaging, and all patients had different levels of enhancement, mainly in the peripheral lesions in the PV phase, showing the "bull's eye" sign, leading to clinical misdiagnosis. Sejal et al[@b9-asm-4-334] studied 3 cases of HEHE patients with MRI findings, and reported that most nodular were in low density in T1WI, and in relatively high density in T2WI under plain scanning, while the center of lesions had low signal, which may be related to tissue hemorrhage, coagulative necrosis, or calcification; "bull's eye" signs were seen in strengthened scanning without intrahepatic bile duct dilatation. Features on CT and MRI have also been reported as "lollipop" signs, describing the tumor lesion as candy, and the vein as rod.[@b10-asm-4-334] In this study, lesions were in low density under plain CT scanning, without local calcifications, and the liver tissue near capsule contractions were commonly seen in 10 patients (66.7%), which, as we considered, were caused by the contraction of abundant collagen fibrous tissues. Dynamic enhanced CT scanning demonstrated peripheral enhancement in the HA phase and even more peripheral enhancement in the PV phase, and ring enhancement were detected under delayed scanning. MRI demonstrated low-density lesions and even lower signal intensity lesion centers in T1WI, but slightly high-intensity lesions and higher signal intensity lesion centers in T2WI. Enhanced MRI scanning showed ring enhancements but no obvious enhanced centers, presenting as "bull's eye" signs. Lesions were further enhanced in delayed MRI scanning. Therefore, 13 out of 15 HEHE cases in our hospital were initially diagnosed with other primary or metastatic liver tumors. However, we still can exclude primary hepatocellular carcinoma, hepatic cavernous hemangioma, and even hepatocholangiocarcinoma and other metastatic hepatic carcinoma and perform positive treatments according to the conclusions drawn from imaging findings, such as lower signal in the tumor center than in the peripheral part under plain scanning, slight enhancement around a tumor in the HA phase, further enhancement in the PV phase, retraction of the tumor surrounding near liver capsule, local calcification, and large feeding vessels inside lesions, etc.

Due to the low malignancy of HEHE, the treatment effectiveness and prognosis are quite inspiring, despite its multiple-nodular onset. The main treatments for HEHE patients nowadays include hepatectomy, live transplantation, minimally invasive surgery, chemotherapy, and radiotherapy, etc. Which therapy is more effective is still under debate because of the lacking of prospective study with large capacity. Kpodonu et al[@b11-asm-4-334] advocated an individualized treatment. Zhu and Li[@b12-asm-4-334] considered that hepatectomy should be done in patients with single or localized tumor, chemotherapy in postoperative patients or patients with no chance of operation (patients with multiple lesions), and radiotherapy only in patients with osseous metastasis to release pain. Other surgeons demonstrated that radical excisions for HEHE patients with lesions limited in 1 lobe can achieve better survivals,[@b13-asm-4-334] even in patients with extrahepatic metastasis.[@b7-asm-4-334]

Zhang et al[@b14-asm-4-334] investigated 7 HEHE patients and pointed out that OLT could be a potential trend in treating a tumor confined to liver. In this study, we performed 13 cases of surgeries (including 4 cases of OLT), among which 7 cases were multiple HEHE and 6 cases were single HEHE, and 3 cases received TACE treatment 1 month after surgeries; the other 2 cases underwent TACE treatment directly after diagnosing HEHE by liver biopsy. Twelve cases in this study survived at the last follow-up. According to our experience, single HEHE patients can be nearly cured after radical resections and multiple HEHE patients can obtain long-term survival time after positive radical resections adjunctive with interventional chemotherapies, which may be related to its low malignant biological behavior.

In conclusion, although there are some imaging features of HEHE, it still lacks typical clinical manifestations and specific iconographic characteristics and presents negative routine tumor marker results, thus causing misdiagnosis. The final diagnosis of HEHE should be confirmed by pathological examinations. Radical resections and even OLT should be considered in single and multiple nodular HEHE, and combining with chemotherapy or radiofrequency ablation, if necessary, good therapeutic effect can be obtained.
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###### 

Treatment and follow-up of 15 HEHE cases (by April 2012).

  Case No.   Treatment                                                                                                                     Postoperative recurrence or metastasis (mo)                                       Postoperative survival time (mo); survival status
  ---------- ----------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------- ---------------------------------------------------
  1          RL tumor resection and liver nodules excavation, with postoperative TACE                                                      RL recurrence 2 mo after operation, re-perform resection                          45; dead
  2          LL and RL VIII segment resection, cholecystectomy, with postoperative TACE                                                    Extensive metastasis 8 mo after operation, poor liver function                    9; dead
  3          RL (VI, VII, partial VIII segment) resection, LL inferior segment resection, cholecystectomy                                  No recurrence or metastasis                                                       60; tumor-free survival
  4          RL tumor resection                                                                                                            Intrahepatic recurrence and thoracic vertebrae metastasis 38 mo after operation   42; survival with tumor
  5          Right subphrenic tumor resection                                                                                              No recurrence                                                                     38; tumor-free survival
  6          Left external lobe resection, left internal lobe tumor resection, right posterior lobe tumor resection, liver cyst drainage   RL recurrence 12 mo after resection                                               16; dead
  7          RL resection, liver cyst drainage                                                                                             No recurrence or metastasis                                                       28; tumor-free survival
  8          RL tumor resection, RL tumor biopsy, cholecystectomy                                                                          No recurrence or metastasis                                                       24; tumor-free survival
  9          Right posterior lobe tumor resection, cholecystectomy                                                                         No recurrence or metastasis                                                       23; tumor-free survival
  10         LL tumor resection                                                                                                            RL recurrence 20 mo after operation                                               22; survival with tumor
  11         Ultrasound B-guided liver biopsy, TACE treatment 1 and 2 mo later                                                             Multiple metastasis 31 mo after treatment                                         34; dead
  12         Ultrasound B-guided liver biopsy, TACE treatment 1 and 2 mo later                                                             Spleen and lung metastasis 54 moafter treatment                                   58; survival with tumor
  13         RL multiple tumor resections                                                                                                  No recurrence or metastasis                                                       40; survival with tumor
  14         RL tumor resection                                                                                                            No recurrence or metastasis                                                       63; tumor-free survival
  15         RL multiple tumor resections, TACE 1 and 2 and 3 mo after operation                                                           Spleen and lumbar metastasis 26 mo after operation                                30; dead

LL: Left liver lobe, RL: right liver lobe, HEHE: hepatic epithelioid hemangioendothelioma, TACE: transcatheter arterial chemoembolization.
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